The company’s strong revenue performance in the second quarter was driven by a 12.7 percent increase in technology services. Information offerings revenue grew 1.8 percent. Revenue grew across all regions. Emerging markets increased 8.7 percent, or 10.1 percent at constant currency, and developed markets grew 5.5 percent, or 4.4 percent at constant currency versus the same period last year.
Adjusted EBITDA increased 9.2 percent to $226 million, or 9.3 percent on a constant currency basis, compared with the second quarter of 2013. This reflects both the drop-through from revenue growth to Adjusted EBITDA and the impact of continued productivity improvements. Adjusted EBITDA as a percentage of revenue for the quarter improved by a full point to 34.0 percent.
Full-Year Guidance: For the full-year 2014, IMS Health reaffirms guidance for revenue growth of 5 to 6 percent and Adjusted EBITDA growth of 7.5 to 9 percent. Adjusted Net Income is projected to grow 15 to 20 percent.